The Federal Department of Home Affairs has decided that two new autologous cell therapies (CAR-T therapies) for the treatment of blood and lymph gland cancer will in future be covered by compulsory healthcare insurance.

Further, preventive investigations of colorectal cancer will be exempted from the franchise in the Cantons of Fribourg and Basel-Stadt.

In addition to these changes, a number of other adaptations have been made to the Healthcare Benefits Ordinance (SR 832.112.31) and its annexes. All amendments to the ordinance entered into force on 1 January 2020.(1)

Endnotes

(1) For further details please see here.